Insulin aspart, recombinant Subcutaneous and Vabomere Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Vabomere Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: meropenem / vaborbactam
Brand name: Vabomere
Synonyms: Meropenem and vaborbactam, Meropenem and Vaborbactam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Vaccinia
- Insulin aspart, recombinant Subcutaneous-Vaccinia Immune Globulin (Intravenous)
- Insulin aspart, recombinant Subcutaneous-Vaccinia immune globulin, human Intravenous
- Insulin aspart, recombinant Subcutaneous-VacuStim Black
- Insulin aspart, recombinant Subcutaneous-VacuStim Wound Therapy Kit
- Insulin aspart, recombinant Subcutaneous-Vagifem
- Vabomere Injection-Insulin degludec
- Vabomere Injection-Insulin Degludec (U-100) Prefilled Pens
- Vabomere Injection-Insulin Degludec (U-100) Vials
- Vabomere Injection-Insulin Degludec (U-200) Prefilled Pens
- Vabomere Injection-Insulin degludec and liraglutide
- Vabomere Injection-Insulin degludec and liraglutide Subcutaneous